ANI Pharmaceuticals, Inc. (ANIP) Financials
ANIP Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 904.4 million | 471.7 million |
2023-09-30 | 889.9 million | 435.2 million |
2023-06-30 | 859.3 million | 424.9 million |
2023-03-31 | 765.2 million | 425.7 million |
ANIP Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 40.0 million | 5.6 million |
2023-09-30 | 27.6 million | 5.4 million |
2023-06-30 | 13.8 million | 5.2 million |
2023-03-31 | 19.1 million | 4.3 million |
ANIP Net Income
No data available :(
ANIP Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 221.1 million | - | - |
2023-09-30 | 193.1 million | - | - |
2023-06-30 | 161.7 million | - | - |
2023-03-31 | 67.8 million | - | - |
ANIP Shares Outstanding
ANIP Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 4.8 million | 9.9 million | 44.5 million | - |
2023-09-30 | 4.6 million | 11.1 million | 42.0 million | - |
2023-06-30 | 6.8 million | 7.4 million | 38.8 million | - |
2023-03-31 | 2.4 million | 5.9 million | 37.4 million | - |
ANIP Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 131.7 million | 68.6 million |
2023-09-30 | 131.8 million | 48.1 million |
2023-06-30 | 116.5 million | 42.3 million |
2023-03-31 | 106.8 million | 37.7 million |
ANIP
Price: $67.25
52 week price:
Earnings Per Share: 0.85 USD
P/E Ratio: 108.78
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 67658
Ebitda: 16.4 millionMarket Capitalization: 1.4 billion